Revenue Summary of Exact Sciences Corporation

Exact Sciences Corporation's latest annual revenue in 2023 was 2.49 Billion USD , up 19.93% from previous year.
Exact Sciences Corporation's latest quarterly revenue in 2024 Q3 was 708.65 Million USD , up 1.34% from previous quarter.
Exact Sciences Corporation reported a annual revenue of 2.08 Billion USD in annual revenue 2022, up 17.95% from previous year.
Exact Sciences Corporation reported a annual revenue of 1.76 Billion USD in annual revenue 2021, up 18.49% from previous year.
Exact Sciences Corporation reported a quarterly revenue of 699.26 Million USD for 2024 Q2, up 9.68% from previous quarter.
Exact Sciences Corporation reported a quarterly revenue of 708.65 Million USD for 2024 Q3, up 1.34% from previous quarter.

Annual Revenue Chart of Exact Sciences Corporation (2023 - 1998)

Historical Annual Revenue of Exact Sciences Corporation (2023 - 1998)

Year	Revenue	Revenue Growth
2023	2.49 Billion USD	19.93%
2022	2.08 Billion USD	17.95%
2021	1.76 Billion USD	18.49%
2020	1.49 Billion USD	70.19%
2019	876.29 Million USD	92.82%
2018	454.46 Million USD	70.86%
2017	265.98 Million USD	167.66%
2016	99.37 Million USD	151.99%
2015	39.43 Million USD	2093.38%
2014	1.79 Million USD	-56.61%
2013	4.14 Million USD	0.0%
2012	4.14 Million USD	-0.46%
2011	4.16 Million USD	-22.1%
2010	5.34 Million USD	12.32%
2009	4.75 Million USD	648.79%
2008	-867 Thousand USD	-129.54%
2007	2.93 Million USD	-38.21%
2006	4.75 Million USD	11.76%
2005	4.25 Million USD	-13.88%
2004	4.93 Million USD	70.11%
2003	2.9 Million USD	223.41%
2002	897 Thousand USD	1663.32%
2001	50.87 Thousand USD	5086900.0%
2000	1.00 USD	0.0%
1999	- USD	0.0%
1998	- USD	0.0%

Year	Revenue	Revenue Growth
2024 Q1	637.52 Million USD	-1.45%
2024 Q2	699.26 Million USD	9.68%
2024 Q3	708.65 Million USD	1.34%
2023 FY	2.49 Billion USD	19.93%
2023 Q4	646.88 Million USD	2.95%
2023 Q1	602.45 Million USD	8.94%
2023 Q2	622.09 Million USD	3.26%
2023 Q3	628.33 Million USD	1.0%
2022 Q2	521.64 Million USD	7.21%
2022 Q4	552.99 Million USD	5.72%
2022 FY	2.08 Billion USD	17.95%
2022 Q1	486.57 Million USD	2.69%
2022 Q3	523.07 Million USD	0.27%
2021 FY	1.76 Billion USD	18.49%
2021 Q1	402.07 Million USD	-13.78%
2021 Q2	434.81 Million USD	8.14%
2021 Q3	456.37 Million USD	4.96%
2021 Q4	473.81 Million USD	3.82%
2020 Q3	408.36 Million USD	51.88%
2020 FY	1.49 Billion USD	70.19%
2020 Q4	466.33 Million USD	14.2%
2020 Q2	268.86 Million USD	-22.7%
2020 Q1	347.82 Million USD	17.68%
2019 FY	876.29 Million USD	92.82%
2019 Q4	295.57 Million USD	35.09%
2019 Q3	218.8 Million USD	9.47%
2019 Q1	162.04 Million USD	13.33%
2019 Q2	199.87 Million USD	23.34%
2018 Q2	102.89 Million USD	13.95%
2018 Q1	90.29 Million USD	3.31%
2018 Q3	118.29 Million USD	14.96%
2018 Q4	142.98 Million USD	20.87%
2018 FY	454.46 Million USD	70.86%
2017 Q1	48.36 Million USD	37.24%
2017 FY	265.98 Million USD	167.66%
2017 Q4	87.4 Million USD	20.44%
2017 Q3	72.57 Million USD	25.9%
2017 Q2	57.64 Million USD	19.19%
2016 Q2	21.18 Million USD	42.8%
2016 Q3	28.11 Million USD	32.71%
2016 Q1	14.83 Million USD	2.88%
2016 FY	99.37 Million USD	151.99%
2016 Q4	35.24 Million USD	25.35%
2015 Q3	12.63 Million USD	55.59%
2015 Q4	14.42 Million USD	14.15%
2015 Q2	8.11 Million USD	90.32%
2015 Q1	4.26 Million USD	183.64%
2015 FY	39.43 Million USD	2093.38%
2014 Q1	294 Thousand USD	-71.62%
2014 FY	1.79 Million USD	-56.61%
2014 Q4	1.5 Million USD	0.0%
2014 Q3	- USD	0.0%
2014 Q2	- USD	-100.0%
2013 Q2	1.03 Million USD	0.0%
2013 Q3	1.03 Million USD	0.0%
2013 Q1	1.03 Million USD	0.0%
2013 Q4	1.03 Million USD	0.0%
2013 FY	4.14 Million USD	0.0%
2012 Q3	1.03 Million USD	0.0%
2012 FY	4.14 Million USD	-0.46%
2012 Q2	1.03 Million USD	0.0%
2012 Q4	1.03 Million USD	0.0%
2012 Q1	1.03 Million USD	-0.58%
2011 Q3	1.03 Million USD	-0.29%
2011 FY	4.16 Million USD	-22.1%
2011 Q2	1.04 Million USD	0.19%
2011 Q1	1.04 Million USD	-24.36%
2011 Q4	1.04 Million USD	0.29%
2010 Q1	1.29 Million USD	4.42%
2010 Q3	1.35 Million USD	3.2%
2010 Q4	1.37 Million USD	1.4%
2010 FY	5.34 Million USD	12.32%
2010 Q2	1.31 Million USD	1.15%
2009 Q3	1.25 Million USD	-0.16%
2009 FY	4.75 Million USD	648.79%
2009 Q4	1.24 Million USD	-0.96%
2009 Q2	1.25 Million USD	25.8%
2009 Q1	1 Million USD	152.74%
2008 Q3	337 Thousand USD	0.0%
2008 Q4	-1.89 Million USD	-662.61%
2008 FY	-867 Thousand USD	-129.54%
2008 Q1	51 Thousand USD	-90.5%
2008 Q2	- USD	-100.0%
2007 Q4	537 Thousand USD	375.22%
2007 FY	2.93 Million USD	-38.21%
2007 Q1	1.17 Million USD	-0.85%
2007 Q2	1.11 Million USD	-4.7%
2007 Q3	113 Thousand USD	-89.87%
2006 Q4	1.18 Million USD	2.16%
2006 FY	4.75 Million USD	11.76%
2006 Q1	1.19 Million USD	0.76%
2006 Q2	1.22 Million USD	2.26%
2006 Q3	1.15 Million USD	-5.41%
2005 Q4	1.18 Million USD	-0.84%
2005 FY	4.25 Million USD	-13.88%
2005 Q3	1.19 Million USD	91.81%
2005 Q2	623 Thousand USD	-50.04%
2005 Q1	1.24 Million USD	-2.2%
2004 Q1	1.17 Million USD	0.68%
2004 Q2	1.22 Million USD	3.82%
2004 Q4	1.27 Million USD	1.11%
2004 Q3	1.26 Million USD	3.19%
2004 FY	4.93 Million USD	70.11%
2003 Q1	408 Thousand USD	-0.07%
2003 FY	2.9 Million USD	223.41%
2003 Q2	406 Thousand USD	-0.49%
2003 Q3	918 Thousand USD	126.11%
2003 Q4	1.16 Million USD	27.34%
2002 Q1	39.26 Thousand USD	3.93%
2002 Q4	408.29 Thousand USD	-0.29%
2002 Q2	39.95 Thousand USD	1.76%
2002 FY	897 Thousand USD	1663.32%
2002 Q3	409.47 Thousand USD	924.82%
2001 Q2	1.00 USD	0.0%
2001 Q4	37.78 Thousand USD	188.65%
2001 Q1	1.00 USD	0.0%
2001 FY	50.87 Thousand USD	5086900.0%
2001 Q3	13.08 Thousand USD	1308800.0%
2000 FY	1.00 USD	0.0%
1999 FY	- USD	0.0%
1998 FY	- USD	0.0%

Peer Revenue Comparison of Exact Sciences Corporation

Name	Revenue	Revenue Difference
Aspira Women's Health Inc.	9.15 Million USD	-27207.909%
bioAffinity Technologies, Inc.	2.53 Million USD	-98607.482%
Intelligent Bio Solutions Inc.	3.11 Million USD	-80232.324%
Standard BioTools Inc.	106.34 Million USD	-2250.73%
Inotiv, Inc.	572.42 Million USD	-336.698%
Prenetics Global Limited	21.74 Million USD	-11397.049%
Neuronetics, Inc.	71.34 Million USD	-3403.624%
Star Equity Holdings, Inc.	45.78 Million USD	-5359.793%
Castle Biosciences, Inc.	219.78 Million USD	-1037.353%
Psychemedics Corporation	22.09 Million USD	-11212.182%
RadNet, Inc.	1.61 Billion USD	-54.628%
IDEXX Laboratories, Inc.	3.66 Billion USD	31.718%
iSpecimen Inc.	9.92 Million USD	-25078.482%
OpGen, Inc.	3.41 Million USD	-73028.496%
Exagen Inc.	52.54 Million USD	-4657.11%
Bionano Genomics, Inc.	36.11 Million USD	-6821.492%
CareDx, Inc	280.32 Million USD	-791.742%
Check-Cap Ltd.	- USD	-Infinity%
Twist Bioscience Corporation	312.97 Million USD	-698.714%
Guardant Health, Inc.	563.94 Million USD	-343.262%
Biodesix, Inc.	49.08 Million USD	-4992.521%
BioNexus Gene Lab Corp.	9.77 Million USD	-25484.031%
Precipio, Inc.	15.19 Million USD	-16349.075%
Natera, Inc.	1.08 Billion USD	-130.91%
Fulgent Genetics, Inc.	289.21 Million USD	-764.334%
Sera Prognostics, Inc.	306 Thousand USD	-816816.993%
23andMe Holding Co.	219.63 Million USD	-1038.13%
OPKO Health, Inc.	863.49 Million USD	-189.494%
Personalis, Inc.	73.48 Million USD	-3301.922%
Aclaris Therapeutics, Inc.	31.24 Million USD	-7899.507%
Applied DNA Sciences, Inc.	13.36 Million USD	-18600.405%
T2 Biosystems, Inc.	7.19 Million USD	-34652.76%
Neogen Corporation	924.22 Million USD	-170.472%
Myriad Genetics, Inc.	678.4 Million USD	-268.48%
ICON Public Limited Company	8.12 Billion USD	69.215%
NeoGenomics, Inc.	591.64 Million USD	-322.513%
Star Equity Holdings, Inc.	45.78 Million USD	-5359.793%
MDxHealth SA	70.19 Million USD	-3461.275%
Prenetics Global Limited	21.74 Million USD	-11397.049%
Illumina, Inc.	4.5 Billion USD	44.499%
DarioHealth Corp.	20.35 Million USD	-12182.655%
ENDRA Life Sciences Inc.	- USD	-Infinity%
Medpace Holdings, Inc.	1.88 Billion USD	-32.554%
Mainz Biomed B.V.	895.47 Thousand USD	-279054.062%
Trinity Biotech plc	56.83 Million USD	-4298.518%
Sotera Health Company	1.04 Billion USD	-138.234%
bioAffinity Technologies, Inc.	2.53 Million USD	-98607.482%

Global Stocks Search

Exact Sciences Corporation (EXAS)

Revenue Summary of Exact Sciences Corporation

Annual Revenue Chart of Exact Sciences Corporation (2023 - 1998)

Historical Annual Revenue of Exact Sciences Corporation (2023 - 1998)

Peer Revenue Comparison of Exact Sciences Corporation